1. Home
  2. GTBP vs TAOP Comparison

GTBP vs TAOP Comparison

Compare GTBP & TAOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.66

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

TAOP

Taoping Inc.

HOLD

Current Price

$1.99

Market Cap

2.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTBP
TAOP
Founded
1965
1993
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTBP
TAOP
Price
$0.66
$1.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.6M
1.1M
Earning Date
11-14-2025
12-08-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$36,196,786.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$1.81
52 Week High
$4.10
$24.75

Technical Indicators

Market Signals
Indicator
GTBP
TAOP
Relative Strength Index (RSI) 47.17 40.93
Support Level $0.58 $2.03
Resistance Level $0.82 $2.84
Average True Range (ATR) 0.07 0.32
MACD -0.01 -0.00
Stochastic Oscillator 32.15 10.24

Price Performance

Historical Comparison
GTBP
TAOP

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

Share on Social Networks: